# Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety

> **NCT01820143** · PHASE1 · COMPLETED · sponsor: **Il-Yang Pharm. Co., Ltd.** · enrollment: 40 (actual)

## Conditions studied

- Healthy
- Pharmacokinetics
- Pharmacodynamics
- Ilaprazole

## Interventions

- **DRUG:** Ilaprazole
- **DRUG:** Esomeprazole

## Key facts

- **NCT ID:** NCT01820143
- **Lead sponsor:** Il-Yang Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2005-04
- **Final completion:** 2005-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2013-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01820143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01820143, "Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01820143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*